![](/img/cover-not-exists.png)
Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): late toxicity results from a randomised, non-inferiority, phase 3 trial
Aluwini, Shafak, Pos, Floris, Schimmel, Erik, Krol, Stijn, van der Toorn, Peter Paul, de Jager, Hanja, Alemayehu, Wendimagegn Ghidey, Heemsbergen, Wilma, Heijmen, Ben, Incrocci, LucaLanguage:
english
Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(15)00567-7
Date:
March, 2016
File:
PDF, 418 KB
english, 2016